West Pharmaceutical Services Inc. (WST) is Trading Lower on Unusual Volume for December 21

Equities Staff |

West Pharmaceutical Services Inc. (WST) experienced unusually high volume on Dec. 21, as the stock lost 2.3% to a closing price of $60.62. The stock saw 717,829 shares trade hands over the course of the day on 2,835 trades. Given that the stock’s average daily volume over the last month has been 264,087 shares a day, this represents a pretty substantial spike over the norm.

West Pharmaceutical Services Inc. has a P/B ratio of 4.39. It also has a P/E ratio of 47.4. The stock has traded between $64.59 and $48.66 over the last 52-weeks, its 50-day SMA is now $60.66, and its 200-day SMA $57.69.

West Pharmaceutical Services Inc is a manufacturer of components & systems for injectable drug delivery, plastic packaging, delivery system components. Its products include stoppers and seals for vials, prefillable syringe components and systems.

Headquartered in Exton, PA, West Pharmaceutical Services Inc. has 7,000 employees and is currently under the leadership of CEO Eric Green.

For a complete fundamental analysis analysis of West Pharmaceutical Services Inc., check out Equities.com’s Stock Valuation Analysis report for WST. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…